Search for: "Teva Pharmaceuticals"
Results 1241 - 1260
of 1,430
Sort by Relevance
|
Sort by Date
10 Apr 2009, 3:04 pm
Teva Pharmaceuticals, USA, et al., No. 08-1143, N.D. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
25 Mar 2009, 10:00 pm
Teva Pharmaceuticals, USA, 2009 WL 703274 (N.D. [read post]
24 Mar 2009, 8:59 pm
Medicis' initial complaint, which was filed against Barr Pharmaceuticals (which has since been acquired by Teva) in January (see "Court Report," January 13, 2009), alleged infringement of U.S. [read post]
16 Mar 2009, 8:52 pm
(a Teva Pharmaceuticals subsidiary) entered into a settlement agreement that effectively ends a dispute between the two companies over the patent family covering Xopenex ®, an inhaled asthma treatment. [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support in… [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
24 Feb 2009, 9:43 pm
Food and Drug Administration from approving the Abbreviated New Drug Application (ANDA) filed by Defendant-Appellant Teva Pharmaceuticals USA, Inc. [read post]
24 Feb 2009, 2:22 pm
Specifically, Teva changed the particle size manufacturing specification of its active pharmaceutical ingredient and the method of measuring the particle size. [read post]
24 Feb 2009, 10:03 am
Teva Pharmaceuticals (Fed. [read post]
22 Feb 2009, 8:38 pm
Teva Parenteral Medicines Inc. et al.1:09-cv-00105; filed February 18, 2009 in the District Court of DelawareInfringement of U.S. [read post]
13 Feb 2009, 5:00 am
(PharmaLittle) US: PerkinElmer sues Interna to invalidate down syndrome test patent (Law360) US: Monsanto files patent suit against Michigan farmers Earl and Richard Schroeder accusing them of planting pesticide-resistant seeds without paying proper royalties (Law360) US: Case to watch: preclusive effect of prior claim construction: Shire v Sandoz (Patently-O) Products AndroGel (Testosterone) - US: Federal Trade Commission continues campaign against reverse payments, filing complaint… [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in inequitable… [read post]
29 Jan 2009, 3:48 am
Amphastar Pharmaceuticals and Teva (on petition for a writ of certiorari) In a split 2008 decision, the Federal Circuit affirmed a lower court decision holding two Aventis patents unenforceable due to inequitable conduct. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
22 Jan 2009, 2:06 am
As we reported yesterday, the California Supreme Court denied the petitions for review in Wyeth v. [read post]
19 Jan 2009, 2:56 pm
Boston, Massachusetts– According to a January 5, 2009 report by Dow Jones Newswires, Teva Pharmaceutical Industries Ltd. [read post]
8 Jan 2009, 3:43 am
Teva Pharmaceuticals and its subsidiary, Ivax Pharmaceuticals, paid $7 million to the Massachusetts Medicaid program to settle a False Claims Act case.Teva and Ivax are among 13 drug makers sued in 2003 by the state for allegedly inflating prices they reported to national pharmaceutical price-reporting services.Massachusetts has already received $7.48 million in settlements with five other defendants, according to the Massachusetts Attorney General's… [read post]
6 Jan 2009, 11:35 am
Teva Pharmaceuticals, one of the thirteen, has paid $7 million to settle the False Claims Act case brought against them. [read post]
